Pulmovant is a clinical-stage biotechnology company developing innovative therapies for patients suffering from pulmonary diseases. Pulmovant’s first program, mosliciguat is designed to provide an effective, once-daily, inhaled treatment option for patients with pulmonary hypertension (PH). Moslicig... Read more
Org chart
Collapse
Teams
Offices
VaxCare
3 followers
Soleno Therapeutics
2 followers
Colossal Biosciences
9 followers
Cugene
1 follower
Action Behavior Centers
6 followers
Vera Therapeutics
6 followers
ZEO ScientifiX
6 followers
Soar Autism Center
1 follower
Mineralys Therapeutics
3 followers
Othram
3 followers
Enveda Biosciences
2 followers
Capricor Therapeutics
2 followers